Stock image for illustration purposes only - book cover, edition or condition may vary.
Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
Raymond A. Huml
€ 71.13
FREE Delivery in Ireland
Description for Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
Paperback. Series: Springerbriefs in Pharmaceutical Science and Drug Development. Num Pages: 97 pages, 1 black & white illustrations, 3 colour illustrations, 6 black & white tables, biography. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 236 x 156 x 9. Weight in Grams: 168.
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a product’s lifespan on the market due to patent protection itself (or loss of patent protection) or via regulatory exclusivity. Case ... Read more
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a product’s lifespan on the market due to patent protection itself (or loss of patent protection) or via regulatory exclusivity. Case ... Read more
Product Details
Format
Paperback
Publication date
2012
Publisher
Springer-Verlag New York Inc. United States
Number of pages
97
Condition
New
Series
Springerbriefs in Pharmaceutical Science and Drug Development
Number of Pages
82
Place of Publication
New York, NY, United States
ISBN
9781461436812
SKU
V9781461436812
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About Raymond A. Huml
Raymond A. Huml, MS, DVM, RAC is Executive Director of Global Due Diligence in Quintiles Capital Solutions (“Capital”) for Quintiles Transnational Corp. Dr. Huml has over 20 years of experience in the biopharmaceutical industry. In his current position, Dr. Huml identifies risks associated with Quintiles global (US, EU and Japan) product-based investments, working with specialists on all components of the ... Read more
Reviews for Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional